Neo Kuma Ventures
Venture capitalLondon · Pre-Seed–Series A · 2 people tracked
Investment thesis
Neo Kuma Ventures is a London-based venture capital firm that invests in companies developing psychedelic-based treatments for mental illness, spanning compounds, clinics and care delivery, and digital therapeutics. It backs science-led teams from pre-seed through Series A with ticket sizes of roughly £150k to £1m, investing globally with a European emphasis. The firm also engages in sector policy work through partners such as Drug Science.
Team · 2 people
from the firm's website
Frequently asked questions
- What stage does Neo Kuma Ventures invest at?
- Neo Kuma Ventures invests at the Pre-Seed, Seed, Series A stages.
- What sectors does Neo Kuma Ventures focus on?
- Neo Kuma Ventures focuses on Biotech, Digital Health, Healthtech, Mental Health.
- Where is Neo Kuma Ventures located?
- Neo Kuma Ventures is headquartered in London, GB.
Similar investors
MedMountain Ventures (MMV) is an early-stage healthcare investment firm founded by board-certified physicians and seasoned healthcare operators, backing companies that improve patient outcomes and reshape how care is delivered, financed, and accessed.
Mystic Ventures is an early-stage investor backing teams in psychedelic medicine and consciousness expansion, focusing on companies at the intersection of biotechnology, AI, and longevity.
Serendipity Impact VC is an early-stage venture firm backing founders building breakthrough technologies focused exclusively on mental and neuro health.
Asia2G (A2G) Capital is a Silicon Valley venture capital firm investing mainly in early-stage Korean and Asian technology startups expanding globally.
Foreground Capital is a venture capital firm dedicated to investing in the future of women's health, building on its predecessor track record at RH Capital.